Identification of a gain-of-function STAT3 mutation (p.Y640F) in lymphocytic variant hypereosinophilic syndrome

This publication has 18 references indexed in Scilit:

• Genomic landscape of cutaneous T cell lymphoma
  Nature Genetics, 2015
• Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma
  Cancer Cell, 2015
• Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease
  Nature Genetics, 2014
• Phase 1, open-label, dose-escalation, and pharmacokinetic study of STAT3 inhibitor OPB-31121 in subjects with advanced solid tumors
  Cancer Chemotherapy and Pharmacology, 2014
• World Health Organization‐defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management
  American Journal of Hematology, 2014
• Cancer Genome Landscapes
  Science, 2013
• Generation of pathogenic TH17 cells in the absence of TGF-β signalling
  Nature, 2010
• Analysis of Interleukin-21-Induced Prdm1 Gene Regulation Reveals Functional Cooperation of STAT3 and IRF4 Transcription Factors
  Immunity, 2009
• Integration of External Signaling Pathways with the Core Transcriptional Network in Embryonic Stem Cells
  Cell, 2008
• Lymphocytic Variant Hypereosinophilic Syndromes
  Immunology and Allergy Clinics of North America, 2007